His Majesty King Abdullah on Thursday visited the US-based West-Ward Plant in New Jersey, US, a subsidiary of Hikma Pharmaceuticals PLC and its agent in the US.

King Abdullah’s stop-over at the company came ahead of arrival in New York to head the Jordanian delegation to the 70th UN General Assembly meeting.

The King met with Hikma Pharmaceuticals’ Vice Chairman Mazen Darwazeh and board members and was briefed on the Jordanian company’s position in international markets and plans of development.

They also discussed ways to enhance Jordan’s pharmaceutical industry and the country’s potential as a destination of investments in this field.

Hikma is a multinational pharmaceutical group, which was founded in 1978 in Jordan. Its sales worldwide constitute 7 per cent of Jordan’s total exports, and 80 per cent of its pharmaceutical exports.

The company’s operations expand through 27 manufacturing facilities in 11 countries, including the US. It markets its products in 50 countries across the world.